The sale of Archaea, acquired for $4.1bn in 2022, serves as the latest indicator that CEO Meg O’Neill is stripping away non-core divisions to simplify the company’s portfolio. O’Neill has explicitly stated that future operations will be governed by value rather than sentiment, signaling a definitive retreat from the renewables-heavy strategy that dominated the firm’s recent past. This restructuring has already resulted in the closure of the Gelsenkirchen refinery and the departure from the North Sea, leaving the company without petrochemical production in its domestic market for the first time in decades.
BP Pivots Back to Oil as Archaea Biogas Sale Signals Strategy Shift
BP is divesting its US biogas business just days after exiting the North Sea, marking a sharp reversal from its green energy expansion. Under new leadership, the oil giant is shedding assets to prioritize core hydrocarbon production, aiming to silence investor criticism over stagnant returns and missed performance targets.
While the firm pivots, it continues to reap the rewards of market volatility. Second-quarter profits climbed to $5.7bn, comfortably beating analyst forecasts of $5.1bn, largely fueled by rising oil prices linked to Middle East instability. Despite this windfall, the company is tempering expectations for the third quarter, projecting production between 2,100 and 2,250 thousand barrels of oil equivalent per day. O’Neill maintains that these cuts are necessary to address inconsistent delivery and excessive write-offs, framing the current divestment spree as a prerequisite for long-term resilience. Investors responded favorably to the aggressive simplification, with shares climbing 1.2 percent to 559.1p following the announcement.
Comments (0)
No comments yet. Be the first!